RELEVIUM Project’s Post

🌍 INNOVATION: THE ONCOSCREEN PROJECT🌍   We are excited about the advancement of the ONCOSCREEN project, which aims to transform the way colorectal cancer is screened and diagnosed in Europe. 🚀   How does it work? 🔬Comprehensive validation: The tools developed will be tested extensively in clinical trials, with the participation of 4,100 citizens and patients from 10 European countries.   🧑🏻🤝🧑🏽 Participatory approach: ONCOSCREEN will incorporate the opinions and perspectives of citizens and patients through a participatory co-design method, coupled with open innovations and FAIR (Findable, Accessible, Interoperable, and Reusable) data.   🎯 End goal: The end goal is for these innovative solutions to be adopted by public health systems and in daily clinical practice across Europe. ONCOSCREEN’S mission is to make bowel cancer screening more accessible and effective for everyone.   Join us on this journey to improve the detection and treatment of digestive cancers in Europe! 🌟   #ONCOSCREEN #Innovation #Europe #CRC #EarlyDiagnose #ColorectalCancer #EUCancer

🌍 INNOVATION: THE ONCOSCREEN PROJECT🌍   We are excited about the advancement of the ONCOSCREEN project, which aims to transform the way colorectal cancer is screened and diagnosed in Europe. 🚀   How does it work? 🔬Comprehensive validation: The tools developed will be tested extensively in clinical trials, with the participation of 4,100 citizens and patients from 10 European countries.   🧑🏻🤝🧑🏽 Participatory approach: ONCOSCREEN will incorporate the opinions and perspectives of citizens and patients through a participatory co-design method, coupled with open innovations and FAIR (Findable, Accessible, Interoperable, and Reusable) data.   🎯 End goal: The end goal is for these innovative solutions to be adopted by public health systems and in daily clinical practice across Europe. ONCOSCREEN’S mission is to make bowel cancer screening more accessible and effective for everyone.   Join us on this journey to improve the detection and treatment of digestive cancers in Europe! 🌟   #ONCOSCREEN #Innovation #Europe #CRC #EarlyDiagnose #ColorectalCancer #EUCancer

Together we can change the approach to pancreatic cancer!   The role of multidisciplinary collaboration and centralized care is crucial in improving pancreatic cancer patient outcomes. A multistakeholder approach involving the Lombardy Welfare Directorate, clinicians and a patient association, proposed a 𝐡𝐮𝐛-𝐚𝐧𝐝-𝐬𝐩𝐨𝐤𝐞 𝐦𝐨𝐝𝐞𝐥 and a 𝐦𝐮𝐥𝐭𝐢𝐝𝐢𝐬𝐜𝐢𝐩𝐥𝐢𝐧𝐚𝐫𝐲 𝐚𝐩𝐩𝐫𝐨𝐚𝐜𝐡 to pancreatic cancer. This article outlines the process and criteria set forth for  𝐩𝐚𝐧𝐜𝐫𝐞𝐚𝐬 𝐮𝐧𝐢𝐭 𝐢𝐦𝐩𝐥𝐞𝐦𝐞𝐧𝐭𝐚𝐭𝐢𝐨𝐧, aiming to provide a structured framework for enhancing pancreatic cancer care. The Lombardy model offers a structured framework for enhancing pancreatic cancer care, with potential applicability to other regions and countries seeking to improve their cancer care infrastructure. 👉https://lnkd.in/egXnPAH9 Thanks to Gianpaolo Balzano, Michele Reni, Maria Di Bartolomeo, Marta Scorsetti, Augusto Caraceni, Piero Rivizzigno, Alessandro Amorosi, Alessandro Scardoni, Mohammad Abu Hilal, Giovanni Ferrari, Roberto Labianca, Massimo Venturini, Claudio Doglioni, Luca Riva, Riccardo Caccialanza. Humanitas Research Hospital, Humanitas University  Regione Lombardia #research #publication #ScienceDirect

🌍 INNOVATION: THE ONCOSCREEN PROJECT🌍 We are excited about the advancement of the ONCOSCREEN project, which aims to transform the way colorectal cancer is screened and diagnosed in Europe. 🚀 How does it work? 🔬Comprehensive validation: The tools developed will be tested extensively in clinical trials, with the participation of 4,100 citizens and patients from 10 European countries. 🧑🏻🤝🧑🏽 Participatory approach: ONCOSCREEN will incorporate the opinions and perspectives of citizens and patients through a participatory co-design method, coupled with open innovations and FAIR (Findable, Accessible, Interoperable, and Reusable) data. 🎯 End goal: The end goal is for these innovative solutions to be adopted by public health systems and in daily clinical practice across Europe. ONCOSCREEN’S mission is to make bowel cancer screening more accessible and effective for everyone. Join us on this journey to improve the detection and treatment of digestive cancers in Europe! 🌟 https://oncoscreen.health/   #ONCOSCREEN #Innovation #Europe #CRC #EarlyDiagnose #ColorectalCancer #EUCancer

The 6th Annual European Cancer Forum is just ONE WEEK away! 🎉 Our CEO Antonella Cardone will join an incredible lineup of speakers to discuss “Navigating a Changing Cancer Care System” during Session III on 4 December 2024. This year’s theme, “Implementing a Sustainable Future for Cancer Care,” will focus on: 🏥 Optimizing patient pathways for early and effective care. 🔬 Expanding access to innovative screening and diagnostic technologies. 🤝 Showcasing learnings from best practices in early detection and multidisciplinary team care.   Registrations are still open: https://lnkd.in/eYP9ajnA   💭What measures do you think should be implemented to help cancer patients navigate the rapidly evolving cancer care system more effectively? Share your thoughts in the comments below! ⬇️ #EuropeanCancerForum #CancerCareInnovation #CollaborationForHealth #BeatingCancerPlan #FutureOfHealthcare #ECBP #EUCancerPlan #CancerPatientsEurope #CancerScreening #EarlyDetection #HealthEquity #HealthInequalities #EUHEalth #CancerAwareness #Oncology Jacki Davis Tuula Helander Martin Bailey Matias Olsen AI for Social Good EUCOPE - European Confederation of Pharmaceutical Entrepreneurs IHE - The Swedish Institute for Health Economics Digestive Cancers Europe MSD Europe European Oncology Nursing Society (EONS) European Parliamentary Forum Europa Uomo EU Make Sense Campaign Sosiaali- ja terveysministeriö European Commission European Parliament Council of the European Union

For over 3 years, International Cancer Institute, hosts virtual multidisciplinary TumorBoards (#MDT), where a diverse group of healthcare practitioners from across the world join in twice a week (#Mondays 4PM-5PM EAT, #Thursdays 4pm-5pm EAT) via a zoom link to discuss treatment planning for cancer patients presented during these meetings. We also conduct #CMEs routinely (In addition to inviting cases from attendees) in some of these slots to ensure optimal standards of care are maintained across the patients journey #screening #diagnosis #treatment #palliativecare #clinicaltrials #survivorship #qualityoflife #Qualityofcare We are proud to introduce an additional component of #chitecasefiles. With over 10,000 cancer patients treated over the years, I will be routinely presenting some cases from the past and leading the discussion on management of the patients in the current changed landscape. If interested join me and other panelists by subscribing to the VTB.  subscription link: www.intercancer.com/vtb 

Part 2️⃣ of the Series: Insights from BEACON 🔎👀: Understanding Cancer Care Disparities in Central and Eastern Europe: A Patient-Centered Perspective BEACON's publication, "Patients’ Perspectives on Cancer Care Disparities in Central and Eastern European Countries," delves into the unique challenges faced by cancer patients in Slovakia and Croatia. Despite advancements in oncological medicine, disparities in access to comprehensive cancer care persist, particularly in these regions. Through focus group discussions, patients revealed significant barriers such as misinformation, healthcare system inefficiencies, and socio-economic impacts. This study emphasizes the urgent need for targeted interventions to reduce disparities and promote inclusive healthcare across Europe. By amplifying patients' voices, BEACON aims to inform policy changes and resource allocation strategies that can improve cancer care outcomes. 🔗 Explore the publication: https://lnkd.in/dZjx6rDT Veronica Coppini Maria Vittoria Ferrari Margherita Dahò Iva Kirac Ira Renko Dario Monzani Roberto Grasso Gabriella Pravettoni #CancerCare #HealthcareDisparities #PatientVoices #EUHealth #BEACONProject

🚨 New Publication Alert! 🚨 Excited to share the latest research from Dr Huseyin Naci and colleagues published in The Lancet Regional Health – Europe: “Efficacy and Safety of Interim Oncology Treatments Introduced for Solid Tumors during the COVID-19 Pandemic in England." 📄 Key Highlights: • We evaluated 31 interim oncology treatments across 36 cancer indications that were introduced to mitigate risks during the pandemic. • While only 39% of these therapies showed superior efficacy compared to standard treatments, over 50% had improved safety profiles, making them crucial in protecting patients with reduced immune function. • Our findings highlight the importance of adaptability in healthcare, providing insights on how these interim treatments have evolved post-pandemic. This research underscores the value of evidence-based policies during healthcare crises, and we hope it informs future strategies for global cancer care. 🔗 Read the full article https://lnkd.in/esvcvwCr #CancerResearch #Oncology #COVID19 #HealthcareInnovation #MedicalResearch #CancerCare

🌍💡World Cancer Research Day 2024 highlights "Innovation in Cancer Research Drives Progress Toward Health Equity." This theme underscores the importance of ongoing investment in cancer research to improve prevention, diagnosis, and treatment. 🩺✨ Organizations and experts emphasize the need for innovative therapies, early detection, and enhanced patient care. 🧬🔍 The day serves to raise awareness about the vital role of research in advancing cancer care and promoting health equity worldwide. Ishwaria Subbiah, MD, MS, FASCO Cancer Institute NSW Sarah Cannon Research Institute Vivek Subbiah, MD Professor Tracey O'Brien, AM NCI Center for Global Health Erika Hamilton, MD The Dorcas Cancer Foundation Sylvester Comprehensive Cancer Center Miriam Mutebi, MD,MSc,FACS Triparna Sen, PhD, MS, BS Sinead Toomey American Society of Clinical Oncology (ASCO) AORTIC- Africa https://lnkd.in/e_SbpuV4 #2024WorldCancerResearchDay #OncoDaily #Oncology #Cancer #Health #Medicine #PatientCare

Lung connect is proud to partner with Aspire ( Asia Pacific policy review and engagement )for Lung cancer a Singapore based consortium focussing on improving Lung Cancer outcomes in APAC region. The white paper titled - Bridging the Gap: Enhancing Lung Cancer Care and Access in the APAC Region”, was launched yesterday globally. This white paper highlights the state of lung cancer in the APAC region and provides recommendations to drive progress in access, care and outcomes! Lung Connect contributed by sharing information about Lung cancer from the Indian subcontinent #LCAM2024 #lungconnect #lungcancertreatment #LungCancerAwarenessMonth #cancertreatment #cancersupportcommunity #lungcancer #whitepaper The White paper can be accessed from the Aspire website: https://lnkd.in/dt_GV9ZM